These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Evaluation of different staging systems and prognostic analysis of 110 primary gastrointestinal diffuse large B cell lymphoma]. Mao L, Wang X, Wang CY, Xia B, Ning QY, Yang HL, Yu Y, Zhang YZ. Zhonghua Yi Xue Za Zhi; 2019 Jun 25; 99(24):1853-1858. PubMed ID: 31269579 [Abstract] [Full Text] [Related]
6. Diffuse large B-cell lymphoma with central nervous system relapse: prognosis and risk factors according to retrospective analysis from a single-center experience. Shimazu Y, Notohara K, Ueda Y. Int J Hematol; 2009 Jun 25; 89(5):577-83. PubMed ID: 19353238 [Abstract] [Full Text] [Related]
7. [A retrospective analysis of clinical characteristics and prognostic factors for 124 cases of primary gastric lymphomas]. He Y, Wang L, Zhu HY, Liang JH, Wu W, Wu JZ, Xia Y, Cao L, Fan L, Li JY, Xu W. Zhonghua Xue Ye Xue Za Zhi; 2017 Jun 14; 38(6):505-510. PubMed ID: 28655094 [Abstract] [Full Text] [Related]
12. A retrospective study at a single center examining risk factors associated with central nervous system involvement in individuals diagnosed with diffuse large B-cell lymphoma. Chen W, Liu H, Hou SL, Li X, Li L, Lian K, Wu XB, Zhang X. Clin Neurol Neurosurg; 2024 Sep 14; 244():108454. PubMed ID: 39047392 [Abstract] [Full Text] [Related]
13. Presence of a high-grade component in gastric mucosa-associated lymphoid tissue (MALT) lymphoma is not associated with an adverse prognosis. Ang MK, Hee SW, Quek R, Yap SP, Loong S, Tan L, Tao M, Lim ST. Ann Hematol; 2009 May 14; 88(5):417-24. PubMed ID: 18777110 [Abstract] [Full Text] [Related]
14. Clinical Characteristics and Prognostic Factors in Primary Breast Diffuse Large B-Cell Lymphoma. Chen GL, Li D, Cao S, Jiang S, Zhang Q, Jin J, Xia Z, Liu Y, Liu X, Zhu Y, Chen Y, Gu L, Hong X, Cao J, Tao R, Lv F. Mediterr J Hematol Infect Dis; 2022 May 14; 14(1):e2022066. PubMed ID: 36119461 [Abstract] [Full Text] [Related]
15. [Comparison the efficacy and prognosis of different first-line treatment for elderly diffuse large B-cell lymphoma]. Liu P, Jiang SY, He XH, Qin Y, Gui L, Zhou SY, Yang JL, Yang S, Wen TY, Shi YK. Zhonghua Zhong Liu Za Zhi; 2020 Mar 23; 42(3):234-241. PubMed ID: 32252203 [Abstract] [Full Text] [Related]
16. [Influence of Peripheral Blood Lymphocyte/Monocyte ratio (LMR) and Its Ratio to Lactate Dehydrogenase on Prognosis of Patients with Diffuse Large B-Cell Lymphoma]. Yang D, Su LP. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Oct 23; 28(5):1563-1569. PubMed ID: 33067955 [Abstract] [Full Text] [Related]
18. Clinical characteristics and outcomes of patients with diffuse large B cell lymphoma treated with R-CHOP-like or CHOP-like regimens: an 8-year experience from a single center. Huang H, Fan L, Fu D, Lin Q, Shen J. Ann Palliat Med; 2020 Jul 23; 9(4):1442-1452. PubMed ID: 32648457 [Abstract] [Full Text] [Related]
19. Outcome of patients with diffuse large B-cell lymphoma and testicular involvement - real world data. Mocikova H, Janikova A, Sykorova A, Prochazka V, Pirnos J, Duras J, Kopeckova K, Steinerova K, Pytlik R, Blahovcova P, Salek D, Kozak T, Bachanova V, Belada D. Ann Hematol; 2024 Oct 01. PubMed ID: 39352469 [Abstract] [Full Text] [Related]
20. Infused Autograft Absolute Lymphocyte Count Predicts Superior Survival in Diffuse Large B Cell Lymphoma Patients Post-Autologous Peripheral Blood Hematopoietic Stem Cell Transplantation: A Matched Case-Control Study. Porrata LF, Burgstaler EA, Winters JL, Jacob E, Inwards DJ, Ansell SM, Micallef IN, Johnston PB, Villasboas J, Paludo J, Markovic SN. Transplant Cell Ther; 2021 Sep 01; 27(9):769.e1-769.e8. PubMed ID: 34091071 [Abstract] [Full Text] [Related] Page: [Next] [New Search]